Astaxanthin attenuated pressure overload-induced cardiac dysfunction and myocardial fibrosis: Partially by activating SIRT1
- 12 March 2017
- journal article
- Published by Elsevier BV in Biochimica et Biophysica Acta (BBA) - General Subjects
- Vol. 1861 (7), 1715-1728
- https://doi.org/10.1016/j.bbagen.2017.03.007
Abstract
No abstract availableKeywords
Funding Information
- Major Projects of National Science and Technology of China (2012ZX09303016-003)
- Natural Science Foundation of China (81600220, 81400330)
- Shandong Provincial Natural Science Foundation (BS2014YY020, BS2014YY021)
- Science and Research Project of Qilu Hospital (26010175616056)
This publication has 44 references indexed in Scilit:
- Dasatinib Attenuates Pressure Overload Induced Cardiac Fibrosis in a Murine Transverse Aortic Constriction ModelPLOS ONE, 2015
- Oral Astaxanthin Supplementation Prevents Peritoneal Fibrosis in RatsPeritoneal Dialysis International, 2015
- Smad3 Signaling Promotes Fibrosis While Preserving Cardiac and Aortic Geometry in Obese Diabetic MiceCirculation: Heart Failure, 2015
- Astaxanthin prevents pulmonary fibrosis by promoting myofibroblast apoptosis dependent on Drp1‐mediated mitochondrial fissionJournal of Cellular and Molecular Medicine, 2015
- Astaxanthin: Sources, Extraction, Stability, Biological Activities and Its Commercial Applications—A ReviewMarine Drugs, 2014
- Protective Effect of Astaxanthin on Liver Fibrosis through Modulation of TGF-1 Expression and AutophagyMediators of Inflammation, 2014
- The pathogenesis of cardiac fibrosisCellular and Molecular Life Sciences, 2013
- Novel astaxanthin prodrug (CDX-085) attenuates thrombosis in a mouse modelThrombosis Research, 2010
- Astaxanthin ameliorates features of metabolic syndrome in SHR/NDmcr-cpLife Sciences, 2007
- Astaxanthin Limits Exercise-Induced Skeletal and Cardiac Muscle Damage in MiceAntioxidants and Redox Signaling, 2003